JASPER THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN FIRST COHORT OF PHASE 2 RENAL BASKET STUDY EVALUATING VENSOBAFUSP ALFA (KP104) IN IGA NEPHROPATHY

Reuters · 1d ago

Please log in to view news